ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1178

Self-Perceived Knowledge of Myositis Among Social Media Respondents- a Pilot Study on Twitter

Srijan Mittal1, Vanshita Batra1, Parikshit Sen2, Saadia Sasha Ali3, Arpit Mago4, Mark Russell5, Eugenia Gkiaouraki6 and Rohit Aggarwal6, 1Maulana Azad Medical College, New Delhi, India, 2Maulana Azad Medical College, 2-Bahadurshah Zafar Marg, New Delhi, Delhi-110002, India., Dalhi, India, 3King's College Hospital, Epsom, United Kingdom, 4Jawaharlal Nehru Medical College, Belgaum, India, 5King's College Hospital, London, United Kingdom, 6University of Pittsburgh, Pittsburgh, PA

Meeting: ACR Convergence 2023

Keywords: Education, Myositis, Outcome measures, Social support, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1155–1182) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Myositis is a rare complex autoimmune disease that is less known and poorly understood, with increased effort required for education of practitioners, students, educators, and patients. Social media platforms offer immense potential for rare disease education, though assessment of baseline knowledge is crucial to develop a comprehensive health education program disseminated through social media. We assessed the current level of knowledge and understanding of myositis, and explored preferred methods of learning, among social media respondents to develop a social media-based myositis education program.

Methods: A validated, pilot tested baseline self-reporting survey was circulated on Twitter, and all respondents >18 years were invited to participate. The survey collected data on demographics, country of residence, profession, and sources of health-related information used for learning. Respondents reported their perceived level of knowledge of myositis on a 5-point Likert scale from 1 (very low) to 5 (very high). Level of knowledge, pattern of twitter activity, and sources of health information used were compared between the different groups through descriptive statistics.

Results: A total of 504 participants responded to the survey, with 48.2% females, ranging from 18-20 to >70 years, with most in the 30–40-year age group (31.1%), from 66 countries across six continents, mostly from the United States (37.5%), India (15.66%) and the United Kingdom (5.79%) (Fig 1A). Respondents included patients (25.2%), trainees (26.1%) from medical student to residents and fellows, as well as faculty (27.8%) from various specialties (Figure 1B, Table 1). The overall knowledge of myositis increased with a higher level of medical training with mean (SD) score of 2.5 (0.9) in medical students, 2.8 (0.8) in residents, 3.3 (0.6) in fellows, and 3.9 (0.6) among attending rheumatologists, where 1 was ‘very low’ while 5 was ‘very high’. Importantly, the overall knowledge of myositis amongst myositis patients and autoimmune patients were 3.1 (0.9) and 2.1 (1.0) respectively indicating a low to medium level (Fig 2A). Myositis pathogenesis was least understood followed by myositis ILD and myositis complications. Social media was reported as the most common platform to be used amongst all respondents for medical educational content, however traditional in person and online lectures remain important for medical personnel (Fig 2B). Patients clearly favored social media for their knowledge.

Conclusion: The overall knowledge of myositis remains low amongst patients. In the medical community overall myositis knowledge is low to moderate among trainees, though increases medical training progresses. Social media is commonly used by patients, students and doctors to access educational content on myositis, though traditional lectures remain important among the medical community. This provides an excellent means to educate patients and clinicians alike about this rare condition which may in turn may improve patient outcomes.

Supporting image 1

Table 1. Demographic, level of current knowledge and use of educational platforms of respondents

Supporting image 2

Fig 1. Country-wise (A) and specialty wise (B) distribution of respondents

Supporting image 3

Fig 2. Self-reported level of knowledge on topics in myositis (1 very low, 2 Low, 3 Medium, 4 High, 5 Very High) (A) and use of educational platforms for medical or patient educational content/material by respondent (0 never, 1 rarely, 3 sometimes, 4 often, 5 regularly) (B)


Disclosures: S. Mittal: None; V. Batra: None; P. Sen: None; S. Ali: None; A. Mago: None; M. Russell: Biogen, 6, Galapagos, 6, Lilly, 6, 12, educational, Menarini, 6, UCB, 12, educational; E. Gkiaouraki: None; R. Aggarwal: Actigraph, 2, Alexion, 2, ANI Pharmaceuticals, 2, Argenx, 2, AstraZeneca, 2, Boehringer-Ingelheim, 2, 5, Bristol-Myers Squibb(BMS), 2, 5, CabalettaBio, 2, Capella Bioscience, 2, Corbus, 2, CSL Behring, 2, EMD Serono, 2, 5, Galapagos, 2, Horizon Therapeutics, 2, I-Cell, 2, Janssen, 2, 5, Kezar, 2, Kyverna, 2, Mallinckrodt, 5, Merck, 2, Octapharma, 2, Pfizer, 2, 5, Q32, 5, Roivant, 2, Sanofi, 2, Teva, 2.

To cite this abstract in AMA style:

Mittal S, Batra V, Sen P, Ali S, Mago A, Russell M, Gkiaouraki E, Aggarwal R. Self-Perceived Knowledge of Myositis Among Social Media Respondents- a Pilot Study on Twitter [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/self-perceived-knowledge-of-myositis-among-social-media-respondents-a-pilot-study-on-twitter/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/self-perceived-knowledge-of-myositis-among-social-media-respondents-a-pilot-study-on-twitter/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology